The South Africa–Cuba Biotechnology Collaboration Call invites South African entities to partner with Cuban organisations in developing, transferring, and commercialising cutting-edge biotechnology products.
Jointly launched by the Technology Innovation Agency (TIA) in Pretoria and BioCubaFarma in Havana, the initiative aims to accelerate the joint development and global commercial launch of biotech innovations.
Building on a framework agreement signed in July 2025, the collaboration focuses on bringing biotechnological solutions from both nations to international markets. It also prioritises the transfer of Cuban technologies and joint research targeting neurodegenerative diseases, lung cancer, and other critical health conditions.
Funding details
The programme offers both financial and non-financial support to help eligible partners move their innovations from research to market.
Successful applicants will gain:
-
Access to Cuban-developed technologies.
-
Opportunities for cross-border collaboration.
-
Inclusion in global commercialisation initiatives and biotech networks.
Who Can Apply
Eligible applicants include:
-
Research institutions
-
Universities
-
Biotechnology companies
-
Organisations involved in diagnostics, clinical research, or therapeutic development with biotech capabilities
Submission details
Applicants must submit an Expression of Interest (EOI) using the questionnaire and technology profile available on the TIA website.
Submissions should demonstrate the applicant’s capacity for technology transfer or joint development.
Deadline
Visit the TIA website to submit your application before the December 5 deadline.
Explore our Opportunities page for more international openings.
Summary not available at this time.
